This guide is educational information, not personal medical advice. The source-check date records editorial work, not a clinician review. Read our medical disclaimer.

Why hepatitis history matters

Hepatitis B and C are different viral infections that affect the liver. NIH recommends screening for both as part of initial HIV care because coinfections and their treatment can affect ART selection and monitoring.

Tell the team about prior diagnoses, treatment, vaccination and liver test results. Bring reports if available, and say when you are uncertain. The team can decide which information or tests are needed rather than assuming an old result describes the current situation.

Sources for this section: [1]

Understand the questions tests answer

Hepatitis tests can address different questions, including evidence of infection or immunity. Ask which tests have been ordered and what each result means in your circumstances. An isolated number or a remembered vaccine dose is not enough to interpret the entire picture.

Ask when results are expected, who will explain them and whether further testing or monitoring is planned. Keep copies alongside your HIV treatment records if you can.

Sources for this section: [1][3]

Hepatitis B and HIV medicines

Some antiretrovirals also act against hepatitis B. For a person with both infections, interruption of hepatitis B-active treatment can lead to reactivation and liver problems. This makes it especially important for the treating teams to coordinate a medication change.

If a refill is delayed or another clinician proposes a change, mention your hepatitis B history and the names of the medicines you use. Ask for an individual plan and do not independently stop or substitute treatment.

Sources for this section: [2]

Ask about vaccination

NIH recommends hepatitis B vaccination for people with HIV who lack protective immunity, with the details depending on their history and clinical situation. Bring your vaccine record and ask whether additional testing or vaccination is appropriate for you.

A vaccine discussion is distinct from deciding how to treat an existing hepatitis infection. Ask your team to explain which question applies and how the response will be checked if needed.

Sources for this section: [3][2]

Keep the teams connected

If different clinicians manage HIV and hepatitis, give each an up-to-date list of medicines, including nonprescription products and supplements. Ask who checks interactions and who communicates laboratory results between teams.

Before leaving, confirm the next appointment, any liver monitoring and a contact for new symptoms or difficulty obtaining treatment. A written plan helps prevent one team from making a decision without knowing what the other has prescribed.

Sources for this section: [2][1]

If hepatitis C treatment is being considered

Hepatitis C is distinct from hepatitis B. NIH guidance says people with HIV and hepatitis C should be evaluated for curative hepatitis C treatment. The choice and timing of medicines require a review of HIV treatment, other medicines and liver health.

If you also have current or previous hepatitis B, tell the hepatitis C team before treatment begins. NIH notes that hepatitis B can reactivate during hepatitis C treatment, so the teams need a coordinated plan for hepatitis B assessment and management. Ask who will follow liver tests and communicate the results.

Sources for this section: [2][1][4]

Which hepatitis result should I ask about?

The term hepatitis describes liver inflammation; hepatitis B and hepatitis C are different viruses and their tests do not mean the same thing. Your clinician may use a combination of blood tests to determine current infection, past exposure or immunity. For hepatitis C, an antibody result may be followed by an RNA test to determine whether infection is currently present.

Ask which virus each result concerns and whether another test is pending. Bring vaccination and treatment records if available, but do not delay care because they are incomplete. If you receive care from more than one clinic, ask how the results will be shared.

Sources for this section: [1][2][4]

Check the source

Sources & editorial note

We use the sources below to support this guide. Follow a source link for its full guidance and any later changes. Source checking does not replace medical review or a conversation with your care team.

  1. Laboratory Testing for Initial Assessment and Monitoring NIH ClinicalInfo. Accessed .
  2. Hepatitis B Virus/HIV Coinfection NIH ClinicalInfo. Accessed .
  3. Immunizations for Preventable Diseases in Adults and Adolescents With HIV NIH ClinicalInfo. Accessed .
  4. Hepatitis C Virus/HIV Coinfection NIH ClinicalInfo. Accessed .

Prepared by HIV Guide editorial team. How we write and check our guides · Contact and corrections information